Peer-reviewedCC BY-NC-NDJAMA network open1 Oct 2026

Changes in Point-of-Sale Drug Prices After Medicare Eliminated Retroactive Pharmacy Fees

Benjamin N. Rome¹
Christopher L. Cai¹
Jason B. Gibbons¹
Aaron S. Kesselheim¹
Kelly E. Anderson¹

¹Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

Abstract

This cross-sectional study evaluates associations between Medicare elimination of retroactive pharmacy fees and point-of-sale drug prices.

Changes in agricultural commodity prices and household consumption of skilled workforce after COVID-19 movement restrictions in Bangladesh
Md Abdur Rouf Sarkar, Mou Rani Sarker, M. Nahid Sattar +11
Scientific Reports1 Jul 2026Peer-reviewedCC BYFull textGeneral medicineDOAJ
Renal artery covered stent placement eliminated false lumen perfusion after provisional extension to induce complete attachment
Keiichi Ishida, Yoshiaki Katada, Hitoshi Nakanowatari +2
Journal of vascular surgery cases and innovative techniques6 Sep 2026Peer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
Displayed pack prices versus standardized unit prices in Riyadh online supermarkets: implications for public health price monitoring
Khalid A. Aldubayan
Frontiers in Public Health2 Nov 2026Peer-reviewedCC BY 4.0Epidemiology & public healthFrontiersCrossref
Potential Cost of Multi-Cancer Detection Tests to Medicare
L. D. Scherer, D. D. Matlock, J. Cronin +1
medRxiv24 Aug 2026PreprintAll rights reservedFull textEpidemiology & public healthmedRxiv
What Medicare Claims Tell Us About Cancer Disparities in American Indian and Alaska Native Peoples
Cole Allick, Denise A. Dillard
JAMA Network Open7 Oct 2026Peer-reviewedCC BY 4.0OncologyCrossref

Cite

BibTeX RIS

BibTeX

@article{rome2026changes,
  title = {{Changes in Point-of-Sale Drug Prices After Medicare Eliminated Retroactive Pharmacy Fees}},
  author = {Benjamin N. Rome and Christopher L. Cai and Jason B. Gibbons and Aaron S. Kesselheim and Kelly E. Anderson},
  journal = {JAMA network open},
  year = {2026},
  month = oct,
  doi = {10.1001/jamanetworkopen.2026.38776},
  url = {https://europepmc.org/article/PMC/PMC13662663},
  note = {CC BY-NC-ND},
}

RIS

TY  - JOUR
TI  - Changes in Point-of-Sale Drug Prices After Medicare Eliminated Retroactive Pharmacy Fees
AU  - Benjamin N. Rome
AU  - Christopher L. Cai
AU  - Jason B. Gibbons
AU  - Aaron S. Kesselheim
AU  - Kelly E. Anderson
PY  - 2026
DA  - 2026/10/01
JO  - JAMA network open
DO  - 10.1001/jamanetworkopen.2026.38776
UR  - https://europepmc.org/article/PMC/PMC13662663
AB  - This cross-sectional study evaluates associations between Medicare elimination of retroactive pharmacy fees and point-of-sale drug prices.
SN  - 2574-3805
ER  -

Abstract

Related

Cite